Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway - PubMed (original) (raw)
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Hui-Wen Lo et al. Cancer Cell. 2005 Jun.
Free article
Abstract
Epidermal growth factor receptor (EGFR) exists in the nucleus of highly proliferative cells where it functions as a transcription factor. Although EGFR has transactivational activity, it lacks a DNA binding domain and, therefore, may require a DNA binding transcription cofactor for its transcriptional function. Here, we report that EGFR physically interacts with signal transducers and activators of transcription 3 (STAT3) in the nucleus, leading to transcriptional activation of inducible nitric oxide synthase (iNOS). In breast carcinomas, nuclear EGFR positively correlates with iNOS. This study describes a mode of transcriptional control involving cooperated efforts of STAT3 and nuclear EGFR. Our work suggests that the deregulated iNOS/NO pathway may partly contribute to the malignant biology of tumor cells with high levels of nuclear EGFR and STAT3.
Similar articles
- Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.
Lo HW, Hung MC. Lo HW, et al. Br J Cancer. 2006 Jan 30;94(2):184-8. doi: 10.1038/sj.bjc.6602941. Br J Cancer. 2006. PMID: 16434982 Free PMC article. Review. - Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL. Real PJ, et al. Oncogene. 2002 Oct 31;21(50):7611-8. doi: 10.1038/sj.onc.1206004. Oncogene. 2002. PMID: 12400004 - Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC. Hanada N, et al. Mol Carcinog. 2006 Jan;45(1):10-7. doi: 10.1002/mc.20147. Mol Carcinog. 2006. PMID: 16299810 - EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact.
Li CF, Fang FM, Wang JM, Tzeng CC, Tai HC, Wei YC, Li SH, Lee YT, Wang YH, Yu SC, Shiue YL, Chu PY, Wang WL, Chen LT, Huang HY. Li CF, et al. Ann Surg Oncol. 2012 Feb;19(2):443-54. doi: 10.1245/s10434-011-1942-6. Epub 2011 Jul 15. Ann Surg Oncol. 2012. PMID: 21761100 - ADAM metalloproteases and EGFR signalling.
Gee JM, Knowlden JM. Gee JM, et al. Breast Cancer Res. 2003;5(5):223-4. doi: 10.1186/bcr637. Epub 2003 Jul 21. Breast Cancer Res. 2003. PMID: 12927027 Free PMC article. Review. No abstract available.
Cited by
- Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D, Sirkisoon S, Carpenter RL, Aguayo NR, Regua AT, Anguelov M, Manore SG, Arrigo A, Jalboush SA, Wong GL, Yu Y, Wagner CJ, Chan M, Ruiz J, Thomas A, Strowd R, Lin J, Lo HW. Doheny D, et al. Oncogene. 2020 Oct;39(42):6589-6605. doi: 10.1038/s41388-020-01454-1. Epub 2020 Sep 14. Oncogene. 2020. PMID: 32929154 Free PMC article. - FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior.
Chioni AM, Grose R. Chioni AM, et al. J Cell Biol. 2012 Jun 11;197(6):801-17. doi: 10.1083/jcb.201108077. Epub 2012 Jun 4. J Cell Biol. 2012. PMID: 22665522 Free PMC article. - Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.
Lo HW, Hung MC. Lo HW, et al. Br J Cancer. 2006 Jan 30;94(2):184-8. doi: 10.1038/sj.bjc.6602941. Br J Cancer. 2006. PMID: 16434982 Free PMC article. Review. - Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.
Pu YS, Huang CY, Kuo YZ, Kang WY, Liu GY, Huang AM, Yu HJ, Lai MK, Huang SP, Wu WJ, Chiou SJ, Hour TC. Pu YS, et al. J Biomed Sci. 2009 Sep 12;16(1):82. doi: 10.1186/1423-0127-16-82. J Biomed Sci. 2009. PMID: 19747398 Free PMC article. - The targets of curcumin.
Zhou H, Beevers CS, Huang S. Zhou H, et al. Curr Drug Targets. 2011 Mar 1;12(3):332-47. doi: 10.2174/138945011794815356. Curr Drug Targets. 2011. PMID: 20955148 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- CA 09299/CA/NCI NIH HHS/United States
- CA16672/CA/NCI NIH HHS/United States
- P0-1 CA99031/CA/NCI NIH HHS/United States
- P20 CA101936/CA/NCI NIH HHS/United States
- P50 83639/PHS HHS/United States
- R0-1 CA109311/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous